上海医药：“缩宫素注射液”等药品产品取得注册证

Core Viewpoint - Shanghai Pharmaceuticals has received drug registration certificates from the Philippines Food and Drug Administration for its Oxytocin Injection and Acetate Octreotide Injection, allowing these products to be marketed [2] Group 1 - Shanghai Pharmaceuticals announced the approval of its Oxytocin Injection and Acetate Octreotide Injection for sale in the Philippines [2] - The approval signifies a potential expansion of the company's market presence in Southeast Asia [2]